However, PIK3C2A expression was significantly increased in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD) (Figure 1A). The gene discussed is PIK3C2A; the disease is cholangiocarcinoma.